Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. J. Finkelstein currently holds 1,712,991 shares of REGENERX BIOPHARMACEUTICALS INC (RGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. J. Finkelstein has been a net seller of RGN stock. They have purchased $30.7K and sold $350.0K worth of shares.
J. J. Finkelstein's most recent insider trade was on Jun 30, 2021, when they purchased 75,000 shares at $0.20 per share.
J. J. Finkelstein serves as Executive at REGENERX BIOPHARMACEUTICALS INC (RGN). They have executed 23 insider transactions totaling $380.7K over their tenure at the company.
J. J. Finkelstein holds the position of Executive at REGENERX BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
J. J. Finkelstein has shown a selling trading pattern, with $30.7K in total purchases and $350.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by J. J. Finkelstein was on May 26, 2006, when they sold $350.0K worth of RGN shares. This transaction involved 125,000 shares at $2.80 per share.
J. J. Finkelstein currently owns 1,712,991 shares of REGENERX BIOPHARMACEUTICALS INC (RGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. J. Finkelstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. J. Finkelstein has 23 Form 4 filings on record as an insider at REGENERX BIOPHARMACEUTICALS INC.
Set alerts for J. J. Finkelstein and 40,000+ other insiders.